Gastrointestinal Archives - Page 2 Of 6

Defibrotide sodium for injection

Facts about Defibrotide sodium for injection

Approval Date: 1991
Proprietary Name: On Request
Active Ingredient(s): Defibrotide sodium for injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Defibrotide sodium for injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

docetaxel Injection

Prostate, Breast Cancer, Gastrointestinal, Head And Neck, Lung

docetaxel Injection
for intravenous use Initial U.S. Approval: 1996

docetaxel Injection is a prescription anticancer medicine used to treat certain people with: • breast cancer • non-small cell lung cancer • prostate cancer • stomach cancer • head and neck cancer It is not known if TAXOTERE is effective in children. What are the ingredients in TAXOTERE? Active ingredient: docetaxel Inactive ingredients: polysorbate 80 and dehydrated alcohol solution.

Facts about docetaxel Injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): docetaxel Injection
Dosage Forms And Strengths: Injection: One-vial TAXOTERE: Single-dose vials 20 mg/mL and 80 mg/4 mL
Company: sanofi aventis
Current indications:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import docetaxel Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

durvalumab injection

Liver

durvalumab injection
for intravenous use Initial U.S. Approval: 2017

Imfinzi (durvalumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma (bladder cancer) and unresectable, stage III non-small cell lung cancer (NSCLC).

Facts about durvalumab injection

Disease Indications-Urothelial Carcinoma, Lung Cancer
Manufacturer-AstraZeneca Pharmaceuticals LP
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “durvalumab injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

encorafenib capsules

Colon, Skin

encorafenib capsules,
for oral use Initial U.S. Approval: 2018

Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called ‘BRAF V600’.

Facts about encorafenib capsules

Disease Indications-Colorectal Cancer, Skin Cancer
Manufacturer-Pierre Fabre Medicament
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “encorafenib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Enfortumab Vedotin-EJFV for Injection

Urothelial Carcinoma, Bladder

enfortumab vedotin-ejfv for injection
for intravenous use Initial U.S. Approval: 2019

Enfortumab Vedotin-EJFV for Injection is a “used to treat bladder cancer and cancers of the urinary tract“. PADCEV for injection is a “prescription medicine. It is available in “form and strength” For Injection: 20 mg and 30 mg of enfortumab vedotin-ejfv as a lyophilized powder in a single-dose vial for reconstitution. PADCEV for injection can be obtained in India upon request.

To inquire about the “offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Name: PADCEV
Active substance: enfortumab vedotin-ejfv
Disease Indications-Urothelial Carcinoma
Manufacturer-Astellas Pharma Inc.
Usage-1.25 mg/kg intravenous infusion
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

erdafitinib tablets

Gastrointestinal

erdafitinib tablets
for oral use Initial U.S. Approval: 2019

Balversa (erdafitinib) is a medication used for the treatment of patients with locally advanced or metastatic urothelial carcinoma.

Facts about erdafitinib tablets

Disease Indications-Urothelial Carcinoma
Manufacturer-Janssen Pharmaceutica
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “erdafitinib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

everolimus tablets

Breast Cancer, Gastrointestinal, Kidney, Lung

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

FLUOROURACIL injection

Colon, Breast Cancer, Esophageal, Gastrointestinal, Pancreatic

FLUOROURACIL injection
for intravenous use Initial U.S. Approval: 1962

Fluorouracil is a nucleoside metabolic inhibitor indicated for the treatment of patients with • Adenocarcinoma of the Colon and Rectum
• Adenocarcinoma of the Breast • Gastric Adenocarcinoma • Pancreatic Adenocarcinoma

Facts about FLUOROURACIL injection

Approval Date: 1962
Proprietary Name: On Request
Active Ingredient(s): FLUOROURACIL injection
Dosage Forms And Strengths: Injection: 2.5 g in a 50 mL vial in a pharmacy bulk package
Company: Spectrum Pharmaceuticals, Inc.
Current indications: • Adenocarcinoma of the Colon and Rectum • Adenocarcinoma of the Breast • Gastric Adenocarcinoma • Pancreatic Adenocarcinoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import FLUOROURACIL injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Fruquintinib Capsules, for oral use Initial U.S. Approval: 2023

Colon

Fruquintinib Capsules, for oral use Initial U.S. Approval: 2023

Fruquintinib is used to treat colorectal cancer (cancer of the colon or rectum) that has spread throughout the body in patients who have received other cancer treatments (eg, fluoropyrimidine, oxaliplatin, and irinotecan) that did not work well.

Approval Date: 2023
Proprietary Name: FRUZAQLA
Active Ingredient(s): fruquintinib
FDA-approved use: To treat patients with Colorectal cancer
Dosage Form: Capsules
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Fruquintinib Capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

futibatinib tablets

Gastrointestinal

futibatinib tablets
for oral use Initial U.S. Approval: YYYY

Lytgobi (futibatinib) is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. This medicine was approved by the FDA in the USA on 22 September 2022.

Facts about futibatinib) tablets

Approval Date: 9/30/2022
Proprietary Name: Lytgobi
Active Ingredient(s): futibatinib
DISEASE INDICATIONS-Bile Duct Cancer
MANUFACTURER-Taiho Pharmaceuticals
USAGE-Tablets: 4 mg
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “futibatinib) tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

List of Oncology Medication For

Gastrointestinal

Indian Pharma Network

M: +9891296838 / 9811747774E: med@indianpharmanetwork.co.in

Facts about Defibrotide sodium for injection

Access the best support services globally

docetaxel Injection for intravenous use Initial U.S. Approval: 1996

Facts about docetaxel Injection

Access the best support services globally

durvalumab injection for intravenous use Initial U.S. Approval: 2017

Facts about durvalumab injection

Access the best support services globally

encorafenib capsules, for oral use Initial U.S. Approval: 2018

Facts about encorafenib capsules

Access the best support services globally

enfortumab vedotin-ejfv for injection for intravenous use Initial U.S. Approval: 2019

Facts about your medicine

erdafitinib tablets for oral use Initial U.S. Approval: 2019

Facts about erdafitinib tablets

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

FLUOROURACIL injection for intravenous use Initial U.S. Approval: 1962

Facts about FLUOROURACIL injection

Access the best support services globally

Fruquintinib Capsules, for oral use Initial U.S. Approval: 2023

Access the best support services globally

futibatinib tablets for oral use Initial U.S. Approval: YYYY

Facts about futibatinib) tablets

Access the best support services globally

Contact Info

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

docetaxel Injection
for intravenous use Initial U.S. Approval: 1996

durvalumab injection
for intravenous use Initial U.S. Approval: 2017

encorafenib capsules,
for oral use Initial U.S. Approval: 2018

enfortumab vedotin-ejfv for injection
for intravenous use Initial U.S. Approval: 2019

erdafitinib tablets
for oral use Initial U.S. Approval: 2019

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

FLUOROURACIL injection
for intravenous use Initial U.S. Approval: 1962

futibatinib tablets
for oral use Initial U.S. Approval: YYYY